-+ 0.00%
-+ 0.00%
-+ 0.00%

STOKE THERAPEUTICS - STK-002 PHASE 1 OSPREY STUDY INITIAL DATA EXPECTED IN H1 2027

Reuters·10/29/2026 20:06:43